摘要
以PI3K/Akt信号通路为靶标的小分子抑制剂的研究已成为抗肿瘤新药研究的热点。以GDC-0941为先导物,合成一系列含三氮唑基团的新型PI3K抗肿瘤抑制剂,并进行了体外抗肿瘤活性评价,期望从中筛选出活性优于GDC-0941的新型抗肿瘤候选药物。
The research of small molecule inhibitors targeting at PI3K/Akt singling pathway has become a hot spot for exploration of new anti-tumor drugs.GDC-0941 selected as a leading compound,a novel series of triazole-based PI3K inhibitors were synthesized and evaluated for their anti-proliferative activities in vitro to find novel candidates with more potent activity than GDC-0941.
出处
《化工时刊》
CAS
2010年第5期15-19,77,共6页
Chemical Industry Times
关键词
PI3K
合成
含三氮唑基团抑制剂
抗肿瘤活性
Phosphatidylinositol-3-kinase(PI3K) synthesis triazole-Based Inhibitor anticancer activity